# Carbetocin Versus Oxytocin and Hemodynamic Effects

> **NCT00977769** · PHASE4 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 76 (actual)

## Conditions studied

- Effects of; Anesthesia, in Pregnancy

## Interventions

- **DRUG:** carbetocin 100 µg
- **DRUG:** oxytocin 5 u
- **DRUG:** placebo (NaCl)

## Key facts

- **NCT ID:** NCT00977769
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-08
- **Final completion:** 2011-10
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2014-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977769, "Carbetocin Versus Oxytocin and Hemodynamic Effects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00977769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*